KalVista Pharmaceuticals
KALV
KALV
32 hedge funds and large institutions have $7.6M invested in KalVista Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
32
Holders Change
-15
Holders Change %
-31.91%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
10
Reduced
8
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Goldman Sachs
New York
|
+$319K |
2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$92.5K |
3 |
![]()
Alyeska Investment Group
Chicago,
Illinois
|
+$24K |
4 |
VKH
Virtu KCG Holdings
New York
|
+$18K |
5 |
SFA
Sequoia Financial Advisors
Akron,
Ohio
|
+$10K |
Top Sellers
1 |
![]()
Franklin Resources
San Mateo,
California
|
-$5.24M |
2 |
BC
Broadfin Capital
New York
|
-$4.27M |
3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.3M |
4 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
-$909K |
5 |
OA
Omega Advisors
New York
|
-$353K |